Figure 2From: Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trialsMean change from baseline to endpoint on the 24-hour average pain score (APS) for treatment compared to placebo over 12 to 13 weeks, by duloxetine dose (60 mg and 120 mg) and condition (diabetic neuropathy and fibromyalgia).Back to article page